Performance of soluble suppressor of tumorigenicity-2 as a prognostic marker for severe dengue in adults

被引：0
|
作者：
Teo, Andrew [1 ,2 ,3 ]
Chia, Po Ying [1 ,3 ,4 ]
Yeo, Tsin Wen [1 ,3 ,4 ]
机构：
[1] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
[2] Univ Melbourne, Doherty Inst, Dept Med, Melbourne, Vic, Australia
[3] Natl Ctr Infect Dis, Singapore, Singapore
[4] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore
来源：
JOURNAL OF INFECTION | 2023年 / 87卷 / 06期
关键词：
D O I：
10.1016/j.jinf.2023.10.003
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：592 / 594
页数：3
相关论文
共 50 条
  • [1] Soluble Suppression of Tumorigenicity-2 as a Candidate Prognostic Marker for Stroke A Systematic Review
    Ahmadzadeh, Koohyar
    Dizaji, Shayan Roshdi
    Balabandian, Mohammad
    Ramawad, Hamzah Adel
    Yousefifard, Mahmoud
    ANNALS OF LABORATORY MEDICINE, 2023, 43 (06) : 585 - 595
  • [2] Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure
    Gul, Ibrahim
    Yucel, Oguzhan
    Zararsiz, Abdullah
    Demirpence, Ozlem
    Yucel, Hasan
    Zorlu, Ali
    Yilmaz, Mehmet Birhan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2017, 18 (03): : 200 - 205
  • [3] Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure A Meta-Analysis
    Aimo, Alberto
    Vergaro, Giuseppe
    Passino, Claudio
    Ripoli, Andrea
    Ky, Bonnie
    Miller, Wayne L.
    Bayes-Genis, Antoni
    Anand, Inder
    Januzzi, James L.
    Emdin, Michele
    JACC-HEART FAILURE, 2017, 5 (04) : 280 - 286
  • [4] Prognostic Value of Baseline and Change of Soluble Suppression of Tumorigenicity-2 in Light Chain Cardiac Amyloidosis
    Xin, Anran
    Li, Xinqing
    Huang, Yan
    Zhuang, Xiaofeng
    Zhao, Xuemei
    Wang, Jinxi
    Zhou, Ping
    Zhang, Jian
    Zhang, Yuhui
    CIRCULATION, 2024, 150
  • [5] Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
    Huang, Dong-Hui
    Sun, Hao
    Shi, Jing-Pu
    CHINESE MEDICAL JOURNAL, 2016, 129 (05) : 570 - 577
  • [6] Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
    Huang Dong-Hui
    Sun Hao
    Shi Jing-Pu
    中华医学杂志英文版, 2016, 129 (05) : 570 - 577
  • [7] Prognostic and Diagnostic Value of Plasma Soluble Suppression of Tumorigenicity-2 Concentrations in Acute Respiratory Distress Syndrome
    Bajwa, Ednan K.
    Volk, Jessica A.
    Christiani, David C.
    Harris, R. Scott
    Matthay, Michael A.
    Thompson, B. Taylor
    Januzzi, James L.
    CRITICAL CARE MEDICINE, 2013, 41 (11) : 2521 - 2531
  • [8] Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure
    Oncel, Can Ramazan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2018, 19 (03): : 228 - 228
  • [9] Soluble suppression of tumorigenicity-2 in cardiac amyloidosis, hypertrophic and dilated cardiomyopathy
    Castiglione, V.
    Ghionzoli, N.
    Aimo, A.
    Teresi, L.
    Prontera, C.
    Masotti, S.
    Grigoratos, C.
    Genovesi, D.
    Barison, A.
    Todiere, G.
    Aquaro, G. D.
    Passino, C.
    Emdin, M.
    Vergaro, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 498 - 498
  • [10] Prognostic Value of β1 Adrenergic Receptor Autoantibody and Soluble Suppression of Tumorigenicity-2 in Patients With Acutely Decompensated Heart Failure
    Sun, Yanxiang
    Feng, Li
    Hu, Bing
    Dong, Jianting
    Zhang, Liting
    Huang, Xuansheng
    Yuan, Yong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345